NDC 50742-404
Topotecan
Topotecan
Topotecan is a Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Ingenus Pharmaceuticals, Llc. The primary component is Topotecan Hydrochloride.
| Product ID | 50742-404_067b1d4b-d34e-437f-a777-f4c5f3310032 |
| NDC | 50742-404 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Topotecan |
| Generic Name | Topotecan |
| Dosage Form | Injection, Powder, Lyophilized, For Solution |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 2016-12-07 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA206962 |
| Labeler Name | Ingenus Pharmaceuticals, LLC |
| Substance Name | TOPOTECAN HYDROCHLORIDE |
| Active Ingredient Strength | 4 mg/4mL |
| Pharm Classes | Topoisomerase Inhibitor [EPC],Topoisomerase Inhibitors [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2021-12-31 |